Search the web
Welcome, Guest
[Sign Out, My Account]

Friday, October 24 2014 5:21pm ET - U.S. Markets Closed.
Industry Center - Drug Delivery
Industry Center > Drug Delivery
More On This Industry
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Diagnostic Substances
· Drug Manufacturers - Major
· Drug Manufacturers - Other
· Drug Related Products
· Drugs - Generic
Top Industries
·Auto Manufacturers - Major
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Diversified Computer Systems
·Diversified Investments
·Diversified Utilities
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
·Tobacco Products, Other
Complete Industry List...
Morningstar Inc.
In-depth Company Dossier Reports on over 7,500 publicly traded U.S. companies. Click here for your free report.
Industry Market Summary
Drug Delivery
Composite Value: 1470.6
Today's Change: -0.78%
S&P 500: +0.71%
chart for
[Drug Delivery (^YHOh786)]
Drug Delivery News
Generex / Antigen Express to Participate in 2014 BIO-Europe® Annual International Partnering Conference
Thu 9:30 am ET (PR Newswire)
WORCESTER, Mass. and TORONTO, Oct. 23, 2014 /PRNewswire/ -- Generex Biotechnology Corporation ( (GNBT) today announced that the Company's wholly-owned subsidiary, Antigen Express, Inc. (, will be participating in the 2014 BIO-Europe® Annual International Partnering Conference being held November 3-5 in Frankfurt, Germany. BIO-Europe® is Europe's largest partnering conference serving the global biotechnology industry. The conference annually attracts leading dealmakers from biotech, pharma, and finance along with the most exciting emerging companies. It is regarded as a "must attend" event for the biotech industry. Antigen Express has pioneered a platform technology for activating a key component of the immune system in a specific and non-toxic manner. In particular, the technology allows for the generation of a robust and antigen-specific CD4+ T cells response using virtually any protein one desires to elicit an immune response against. This cell type has been shown to be critical in generating both cellular and antibody responses to a novel pathogen. Cellular responses are important in generating an effective immunological response to cancer while antibody responses comprise the front line defense against infectious agents.
Alkermes to Host Conference Call to Discuss Third Quarter 2014 Financial Results - (Business Wire)
Alkermes’ New Drug Application for Aripiprazole Lauroxil for Treatment of Schizophrenia Accepted for Filing by U.S. FDA - (Business Wire)
More News on Drug Delivery: Latest News,
Industry Top Performers
Intraday Price Performance% ChangeMarket Cap
Intellipharmaceutics Internatio [IPCI] +4.51% $67.2 M
pSivida Corp. [PSDV] +3.93% $119.4 M
BR PHARMA -ON NM [BPHA3.SA] +3.05% $0
PetMed Express, Inc. [PETS] +1.88% $255.4 M
More Top Intraday Price Performers...
Market Capitalization% ChangeMarket Cap
WALGREEN [WGN.DE] +1.37% $46.0 B
Valeant Pharmaceuticals Interna [VRX] +0.87% $42.9 B
FRAGUA-B [FRAGUAB.MX] +0.41% $24.2 B
Alkermes plc [ALKS] +1.39% $6.6 B
More Top Companies by Market Cap...
More Top Performers: by Valuation, by Growth, by Financial Strength
Industry Calendar
Upcoming Events
Date Co Event
10/28/14 600998.SS Jointown Pharmaceutical Group Co Ltd Q3 2014 Earnings Release
10/29/14 ALKS Alkermes Plc Earnings Call (Q3 2014)
10/31/14 FLML Flamel Technologies SA Q3 2014 Earnings Release
More Upcoming Events...
Recent Events
Date Co Event
10/20/14 PETS PetMed Express, Inc. downside earnings surprise (-9.52%)
10/20/14 VRX Valeant Pharmaceuticals Interna upside earnings surprise (+6.03%)
10/15/14 IPCI Intellipharmaceutics Internatio upside earnings surprise (+36.36%)
More Recent Events...
Sponsor Results
Domain Names From $6
$6 domains. Over 45 extensions. Loads of free extras at great prices!
HRP-Based Antibody Arrays
HRP label-based antibody arrays. High sensitivity, many targets!
United Science QuEChERS
A Better Way to Recover your Planar Pesticides. No Toluene. No kidding.
(What's This?)
Locate Industry by Company
Enter Symbol:
Industry Statistics
Market Capitalization:89B
Price / Earnings:NM
Price / Book:-6.0
Net Profit Margin (mrq):-15.7%
Price To Free Cash Flow (mrq):27.4
Return on Equity:0.0%
Total Debt / Equity:139.6
Dividend Yield:0.2%
View Industry Browser
Community Spotlight
Most Active Boards
Board Popularity
Unusually Active Boards
Board Variance

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Drug Delivery Headlines
More Finance RSS Feeds

Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2014 Morningstar, Inc. All Rights Reserved. Company information © 2014 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?